Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -19,828 | N/A | N/A |
| Depreciation Amortization | 101 | N/A | N/A |
| Accounts payable and accrued liabilities | -726 | N/A | N/A |
| Other Working Capital | 551 | N/A | N/A |
| Other Operating Activity | 5,509 | 0 | 0 |
| Operating Cash Flow | $-14,393 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | 1,893 | N/A | N/A |
| PPE Investments | -4 | N/A | N/A |
| Other Investing Activity | -1 | 0 | 0 |
| Investing Cash Flow | $1,888 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 14,000 | N/A | N/A |
| Common Stock Issued | 6 | N/A | N/A |
| Other Financing Activity | -1,596 | 0 | 0 |
| Financing Cash Flow | $12,410 | $N/A | $N/A |
| Beginning Cash Position | 10,104 | N/A | N/A |
| End Cash Position | 10,009 | N/A | N/A |
| Net Cash Flow | $-95 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -14,393 | N/A | N/A |
| Capital Expenditure | -4 | N/A | N/A |
| Free Cash Flow | -14,397 | 0 | 0 |